微信内可能无法直接打开本站。请点右上角 ··· → 在浏览器打开，或复制链接。
STAT+: FDA takes another look at botanical drugs
RSS 官方收录 · 可信分层展示
关键摘要
FDA重新评估植物药审批路径
- FDA正重新审视植物药监管框架
- clozapine临床应用仍存障碍
- 猪肾移植或成人类器官移植过渡方案
AI 摘要 · 来源可核验
正文提要
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Today, we look at the FDA’s interest in botanical drugs, the persistent barriers to clozapine use, and the ways in which pig kidneys could bridge patients to human transplants.
No better place than a SoCal gym to unfurl the mechanics of unapproved peptide trafficking. Trust me.